Ask the Experts: biosimilars

In this ‘Ask the Experts’ feature we will be discussing the use of biosimilars with a number of leading experts across the field. The series will explore the role of biosimilars, address the benefits and challenges of creating them and how they have gained momentum within the pharmaceutical industry. Biosimilars are subsequent versions of an innovator product and have gained popularity over the last 30 years. They possess biologically similar properties to regulatory approved biologics, however, because of the complexity of structure and manufacturing are not identical to the reference product. Regulatory approval of biosimilars requires developers to meet high...

To view this content, please register now for access

It's completely free